Literature DB >> 26807758

Inflammation, fibrosis, and modulation of the process by mesenchymal stem/stromal cells.

Darwin J Prockop1.   

Abstract

Fibrosis and scarring are the end stage of many disease processes. In effect, the collagen fibers that initially provide a necessary strength during the repair of injured tissues are frequently synthesized in excessive amounts and become irreversible fibrotic deposits that limit regeneration of the endogenous cells of a tissue. This review will focus on the potential of mesenchymal stem/stromal cells for treatment of fibrotic diseases, with emphasis on the role of TSG-6 as a mediator of anti-inflammatory effects.
Copyright © 2016 The Author. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Mesenchymal stem/stromal cells; Regenerative medicine; TSG-6; Tissue fibrosis

Mesh:

Substances:

Year:  2016        PMID: 26807758      PMCID: PMC4842094          DOI: 10.1016/j.matbio.2016.01.010

Source DB:  PubMed          Journal:  Matrix Biol        ISSN: 0945-053X            Impact factor:   11.583


  42 in total

1.  Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury.

Authors:  Mohammad Naimul Islam; Shonit R Das; Memet T Emin; Michelle Wei; Li Sun; Kristin Westphalen; David J Rowlands; Sadiqa K Quadri; Sunita Bhattacharya; Jahar Bhattacharya
Journal:  Nat Med       Date:  2012-04-15       Impact factor: 53.440

2.  Density-Dependent Metabolic Heterogeneity in Human Mesenchymal Stem Cells.

Authors:  Yijun Liu; Nathalie Muñoz; Bruce A Bunnell; Timothy M Logan; Teng Ma
Journal:  Stem Cells       Date:  2015-08-14       Impact factor: 6.277

3.  Mitochondrial transfer between cells can rescue aerobic respiration.

Authors:  Jeffrey L Spees; Scott D Olson; Mandolin J Whitney; Darwin J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

4.  Retention of nonhelical procollagen containing cis-hydroxyproline in rough endoplasmic reticulum.

Authors:  J Uitto; H Hoffman; D J Prockop
Journal:  Science       Date:  1975-12-19       Impact factor: 47.728

5.  Expansion of adipose mesenchymal stromal cells is affected by human platelet lysate and plating density.

Authors:  Dominik Cholewa; Thomas Stiehl; Anne Schellenberg; Gudrun Bokermann; Sylvia Joussen; Carmen Koch; Thomas Walenda; Norbert Pallua; Anna Marciniak-Czochra; Christoph V Suschek; Wolfgang Wagner
Journal:  Cell Transplant       Date:  2011-03-07       Impact factor: 4.064

Review 6.  The resolution of inflammation: Principles and challenges.

Authors:  Sarah E Headland; Lucy V Norling
Journal:  Semin Immunol       Date:  2015-04-22       Impact factor: 11.130

7.  Anti-inflammatory protein TSG-6 reduces inflammatory damage to the cornea following chemical and mechanical injury.

Authors:  Joo Youn Oh; Gavin W Roddy; Hosoon Choi; Ryang Hwa Lee; Joni H Ylöstalo; Robert H Rosa; Darwin J Prockop
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-13       Impact factor: 11.205

8.  Phase-directed therapy: TSG-6 targeted to early inflammation improves bleomycin-injured lungs.

Authors:  Andrea M Foskett; Nikolay Bazhanov; Xinyu Ti; April Tiblow; Thomas J Bartosh; Darwin J Prockop
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-11-15       Impact factor: 5.464

Review 9.  TSG-6: a pluripotent inflammatory mediator?

Authors:  C M Milner; V A Higman; A J Day
Journal:  Biochem Soc Trans       Date:  2006-06       Impact factor: 5.407

10.  Mesenchymal stem cells.

Authors:  A I Caplan
Journal:  J Orthop Res       Date:  1991-09       Impact factor: 3.494

View more
  35 in total

Review 1.  Decorin is a devouring proteoglycan: Remodeling of intracellular catabolism via autophagy and mitophagy.

Authors:  Simone Buraschi; Thomas Neill; Renato V Iozzo
Journal:  Matrix Biol       Date:  2017-11-07       Impact factor: 11.583

Review 2.  Extracellular matrix: The driving force of mammalian diseases.

Authors:  Renato V Iozzo; Maria A Gubbiotti
Journal:  Matrix Biol       Date:  2018-04-03       Impact factor: 11.583

3.  Mesenchymal Stromal Cells Inhibit Inflammatory Lymphangiogenesis in the Cornea by Suppressing Macrophage in a TSG-6-Dependent Manner.

Authors:  Hyun Beom Song; Se Yeon Park; Jung Hwa Ko; Jong Woo Park; Chang Ho Yoon; Dong Hyun Kim; Jeong Hun Kim; Mee Kum Kim; Ryang Hwa Lee; Darwin J Prockop; Joo Youn Oh
Journal:  Mol Ther       Date:  2017-10-05       Impact factor: 11.454

Review 4.  The origin of fibrogenic myofibroblasts in fibrotic liver.

Authors:  Tatiana Kisseleva
Journal:  Hepatology       Date:  2017-01-11       Impact factor: 17.425

Review 5.  Mechanisms of liver fibrosis and its role in liver cancer.

Authors:  Debanjan Dhar; Jacopo Baglieri; Tatiana Kisseleva; David A Brenner
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-10

6.  TNFα-stimulated gene-6 (TSG6) activates macrophage phenotype transition to prevent inflammatory lung injury.

Authors:  Manish Mittal; Chinnaswamy Tiruppathi; Saroj Nepal; You-Yang Zhao; Dagmara Grzych; Dheeraj Soni; Darwin J Prockop; Asrar B Malik
Journal:  Proc Natl Acad Sci U S A       Date:  2016-11-28       Impact factor: 11.205

7.  Metabolic reprogramming of murine cardiomyocytes during autophagy requires the extracellular nutrient sensor decorin.

Authors:  Maria A Gubbiotti; Erin Seifert; Ulrich Rodeck; Jan B Hoek; Renato V Iozzo
Journal:  J Biol Chem       Date:  2018-07-26       Impact factor: 5.157

8.  Mesenchymal stem cells protect renal tubular cells via TSG-6 regulating macrophage function and phenotype switching.

Authors:  Yu Zhao; Xiang-Yang Zhu; Turun Song; Lei Zhang; Alfonso Eirin; Sabena Conley; Hui Tang; Ishran Saadiq; Kyra Jordan; Amir Lerman; Lilach O Lerman
Journal:  Am J Physiol Renal Physiol       Date:  2021-02-08

9.  Combined Bone Marrow Aspirate and Platelet-Rich Plasma for Cartilage Repair: Two-Year Clinical Results.

Authors:  Kris Hede; Bjørn B Christensen; Jonas Jensen; Casper B Foldager; Martin Lind
Journal:  Cartilage       Date:  2019-09-20       Impact factor: 3.117

Review 10.  Novel mechanisms and clinical trial endpoints in intestinal fibrosis.

Authors:  Jie Wang; Sinan Lin; Jonathan Mark Brown; David van Wagoner; Claudio Fiocchi; Florian Rieder
Journal:  Immunol Rev       Date:  2021-05-16       Impact factor: 10.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.